Sildenafil Citrate
Product Images NDC 67296-1488

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 67296-1488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

This is a medication called Sildenafil citrate, which comes in the form of film-coated tablets containing 20 mg of sildenafil. It is meant to be taken according to the prescribing doctor's instructions and stored between the temperatures of 20°C-25°C (68°F-77°F), with excursions permitted to 15°C-30°C (59°F-86°F). The tablets should be dispensed in tight containers, kept away from children and the patient information sheet can be obtained from the website mentioned. The medication is distributed by TruPharma, LLC, located in Tampa, FL, and manufactured by Rubicon Research Private Limited in India.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Each tablet contains 20 mg Sildenafil citrate USP which is used for treating erectile dysfunction. The tablets should be stored at a temperature range of 20°C-25°C(68°F-77°F) and in tight containers. The medication should be kept out of the reach of children. It is available in a pack of 90 tablets and is manufactured by Rubicon Research in India. Patient information is available on the website of TruPharma.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

Interacting drugs have been evaluated for fold change and 90% confidence interval (CI). Nodose adjustment is recommended for Acitomycin, Bosentan, Cimetidines, Evomyeint, Maslox, Oral Contraceptives, and Sapionis K8. The AUC accumulation is shown relative to Sildenafil alone from Day 1 to Day 7. The vertical solid line indicates 1. There is no benefit on exercise capacity when Sildenafil is added to Bosentan therapy. Some data related to Cifrical Stcies(14) is also provided.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

This is a drug interaction chart showing the effects of interacting drugs on Acenocoumarol. The fold change and 90% confidence interval recommendations are provided for different drug interactions in terms of INR, AUC, Cmax, and BT. However, due to the lack of context, it is not clear what these abbreviations refer to or whether these interactions are harmful or not. The chart also states that adding sildenafil to bosentan therapy does not benefit exercise capacity. The text also mentions that coadministration of certain drugs such as ritonavir and saquinavir with Acenocoumarol is not recommended.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

This is a table showing changes from baseline (in meters) over 12 weeks for a study that includes placebo and different dosages of Sildenafil (20mg TID, 40mg TID, and 80mg TID). The data is presented for the fourth, eighth, and twelfth weeks.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

This is a medical record that seems to refer to a study on Idiopathic Pulmonary Arterial Hypertension. The text includes dosages, measurements, and demographic information such as age, gender, and functional capacity for patients in the study. However, the text is difficult to interpret due to errors in and fragmented information.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

The given text seems to be a chart or graph that displays the mean change from baseline with different doses of a drug called Sildenafil. It shows the values at different weeks (4, 8, and 12) of a study. The doses of the drug used were 1mg, 5mg, and 20mg taken TID (three times a day). The data is presented in a graph format with the X-axis displaying timelines of the week of the study and the Y-axis showing change from baseline in meters. The data is accompanied by a note explaining that the plotted values represent the mean change from baseline, along with the standard error, for each treatment up to week 12.*

FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.